GROUP ONE TRADING, L.P. - AVADEL PHARMACEUTICALS PLC ownership

AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 59 filers reported holding AVADEL PHARMACEUTICALS PLC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
GROUP ONE TRADING, L.P. ownership history of AVADEL PHARMACEUTICALS PLC
ValueSharesWeighting
Q3 2023$63,685
-80.1%
6,183
-68.2%
0.00%
-100.0%
Q2 2023$319,976
-69.1%
19,416
-82.8%
0.00%
-75.0%
Q1 2023$1,034,778
+441.7%
112,967
+323.5%
0.00%
Q4 2022$191,007
-55.2%
26,677
-57.3%
0.00%
Q1 2022$426,000
-21.8%
62,423
-7.4%
0.00%
Q4 2021$545,000
-16.9%
67,447
+0.8%
0.00%
-100.0%
Q3 2021$656,000
+365.2%
66,888
+216.8%
0.00%
Q4 2020$141,000
-39.7%
21,113
-54.5%
0.00%
-100.0%
Q3 2020$234,000
+1200.0%
46,443
+635.9%
0.00%
Q2 2019$18,000
+800.0%
6,311
+282.7%
0.00%
Q1 2019$2,000
-92.6%
1,649
-84.1%
0.00%
Q4 2018$27,000
-75.9%
10,349
-59.4%
0.00%
-100.0%
Q3 2018$112,000
-8.9%
25,482
+27.1%
0.00%0.0%
Q2 2018$123,000
-48.3%
20,049
-38.7%
0.00%
-50.0%
Q1 2018$238,000
+235.2%
32,715
+280.0%
0.00%
Q4 2017$71,0008,6090.00%
Other shareholders
AVADEL PHARMACEUTICALS PLC shareholders Q4 2018
NameSharesValueWeighting ↓
Broadfin Capital, LLC 4,133,464$45,592,0005.54%
Stonepine Capital Management, LLC 747,863$8,249,0004.45%
JW Asset Management, LLC 444,439$4,902,0003.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,655,494$40,320,0002.15%
ARMISTICE CAPITAL, LLC 1,150,000$12,685,0001.62%
FALCON POINT CAPITAL, LLC 855,101$9,432,0001.27%
Perceptive Advisors 1,429,114$15,763,0000.79%
KNOTT DAVID M 126,463$1,395,0000.58%
HEARTLAND ADVISORS INC 700,000$7,721,0000.50%
Sio Capital Management, LLC 91,413$1,008,0000.48%
View complete list of AVADEL PHARMACEUTICALS PLC shareholders